Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Endogenous epoxygenases are modulators of monocyte/macrophage activity.

Bystrom J, Wray JA, Sugden MC, Holness MJ, Swales KE, Warner TD, Edin ML, Zeldin DC, Gilroy DW, Bishop-Bailey D.

PLoS One. 2011;6(10):e26591. doi: 10.1371/journal.pone.0026591. Epub 2011 Oct 19.

2.

The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.

Wray JA, Sugden MC, Zeldin DC, Greenwood GK, Samsuddin S, Miller-Degraff L, Bradbury JA, Holness MJ, Warner TD, Bishop-Bailey D.

PLoS One. 2009 Oct 12;4(10):e7421. doi: 10.1371/journal.pone.0007421.

3.

PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.

Ali FY, Hall MG, Desvergne B, Warner TD, Mitchell JA.

Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1871-3. doi: 10.1161/ATVBAHA.109.193367. Epub 2009 Aug 20.

PMID:
19696401
4.

Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.

Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2606-11.

PMID:
18029909
5.

Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets.

Moraes LA, Swales KE, Wray JA, Damazo A, Gibbins JM, Warner TD, Bishop-Bailey D.

Blood. 2007 May 1;109(9):3741-4. Epub 2007 Jan 9.

6.

Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.

Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):63-9. Epub 2006 Oct 26.

PMID:
17068288
7.

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.

Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, Bishop-Bailey D.

Cancer Res. 2006 Oct 15;66(20):10120-6.

8.

Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta.

Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA.

FASEB J. 2006 Feb;20(2):326-8. Epub 2005 Dec 20.

PMID:
16368717
9.

Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.

Ali FY, Egan K, FitzGerald GA, Desvergne B, Wahli W, Bishop-Bailey D, Warner TD, Mitchell JA.

Am J Respir Cell Mol Biol. 2006 Feb;34(2):242-6. Epub 2005 Oct 20.

PMID:
16239641
10.

Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy.

Bishop-Bailey D, Hla T, Warner TD.

Circ Res. 2002 Aug 9;91(3):210-7.

PMID:
12169646
11.

Prostaglandins and the regulation of tumor growth.

Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Mitchell JA.

J Environ Pathol Toxicol Oncol. 2002;21(2):93-101. Review.

PMID:
12086407

Supplemental Content

Loading ...
Support Center